Trials / Completed
CompletedNCT02976883
[18F]HX4 PET/CT Imaging for Detection of Hypoxia
A Phase II, Single Centre Exploratory Study of [18F]HX4 PET/CT Imaging to Detect Hypoxia in Patients With Head and Neck and Lung Cancer, Receiving Radiotherapy With Curative Intent
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Nottingham University Hospitals NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the radiotracer \[18F\]HX4 for non-invasive detection of hypoxia in patients with head and neck, or lung cancer. Each participant will undergo a diagnostic \[18F\]HX4 PET/CT scan before beginning radiotherapy treatment. Patient follow up data will be collected from routine appointments, and analysed with the hypoxia scan results to assess whether \[18F\]HX4 PET/CT scanning can predict patient outcome from radiotherapy treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | [18F]HX4 diagnostic PET/CT scan | Single intravenous injection of \[18F\]HX4 and PET/CT scan |
Timeline
- Start date
- 2015-03-31
- Primary completion
- 2017-07-25
- Completion
- 2017-07-25
- First posted
- 2016-11-29
- Last updated
- 2019-01-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02976883. Inclusion in this directory is not an endorsement.